Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marianne Benn

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
Atherosclerosis|February 10, 2009
Apolipoprotein B levels, APOB alleles, and risk of ischemic cardiovascular disease in the general population, a reviewMarianne Benn
Clinical Chemistry|November 22, 2020
LDL-Cholesterol versus Glucose in Microvascular and Macrovascular DiseaseFrida Emanuelsson, Marianne Benn
Cardiovascular Research|February 23, 2018
From genome-wide association studies to Mendelian randomization: novel opportunities for understanding cardiovascular disease causality, pathogenesis, prevention, and treatmentMarianne Benn, Børge G Nordestgaard
Frontiers in Genetics|February 21, 2022
Familial Hypercholesterolemia Prevalence Among Ethnicities-Systematic Review and Meta-AnalysisFrida Toft-Nielsen, Frida Emanuelsson, Marianne Benn
The Journal of Clinical Endocrinology and Metabolism|August 8, 2018
Familial Hypercholesterolemia and Risk of Peripheral Arterial Disease and Chronic Kidney DiseaseFrida Emanuelsson, Børge G Nordestgaard, Marianne Benn
Pharmacology & Therapeutics|November 30, 2013
Remnant cholesterol as a cause of ischemic heart disease: evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatmentAnette Varbo, Marianne Benn, Børge G Nordestgaard
European Heart Journal|October 7, 2025
Genetic variants of glucose-dependent insulinotropic polypeptide (GIP) signalling as proxy for body weight reduction and cardiovascular riskFrida Emanuelsson, Børge G Nordestgaard, Marianne Benn
Atherosclerosis|September 16, 2014
Creatinine, eGFR and association with myocardial infarction, ischemic heart disease and early death in the general populationKirstine L Sibilitz, Marianne Benn, Børge G Nordestgaard
Journal of the American College of Cardiology|June 22, 2019
Low LDL Cholesterol by PCSK9 Variation Reduces Cardiovascular MortalityMarianne Benn, Anne Tybjærg-Hansen, Børge G Nordestgaard
Cardiovascular Research|July 30, 2023
Genetic variation in solute carrier family 5 member 2 mimicking sodium-glucose co-transporter 2-inhibition and risk of cardiovascular disease and all-cause mortality: reduced risk not explained by lower plasma glucoseLouise E Bechmann, Frida Emanuelsson, Børge G Nordestgaard, et al.
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Atherosclerosis|February 10, 2009
Apolipoprotein B levels, APOB alleles, and risk of ischemic cardiovascular disease in the general population, a reviewMarianne Benn
Clinical Chemistry|November 22, 2020
LDL-Cholesterol versus Glucose in Microvascular and Macrovascular DiseaseFrida Emanuelsson, Marianne Benn
Cardiovascular Research|February 23, 2018
From genome-wide association studies to Mendelian randomization: novel opportunities for understanding cardiovascular disease causality, pathogenesis, prevention, and treatmentMarianne Benn, Børge G Nordestgaard
Frontiers in Genetics|February 21, 2022
Familial Hypercholesterolemia Prevalence Among Ethnicities-Systematic Review and Meta-AnalysisFrida Toft-Nielsen, Frida Emanuelsson, Marianne Benn
The Journal of Clinical Endocrinology and Metabolism|August 8, 2018
Familial Hypercholesterolemia and Risk of Peripheral Arterial Disease and Chronic Kidney DiseaseFrida Emanuelsson, Børge G Nordestgaard, Marianne Benn
Pharmacology & Therapeutics|November 30, 2013
Remnant cholesterol as a cause of ischemic heart disease: evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatmentAnette Varbo, Marianne Benn, Børge G Nordestgaard
European Heart Journal|October 7, 2025
Genetic variants of glucose-dependent insulinotropic polypeptide (GIP) signalling as proxy for body weight reduction and cardiovascular riskFrida Emanuelsson, Børge G Nordestgaard, Marianne Benn
Atherosclerosis|September 16, 2014
Creatinine, eGFR and association with myocardial infarction, ischemic heart disease and early death in the general populationKirstine L Sibilitz, Marianne Benn, Børge G Nordestgaard
Journal of the American College of Cardiology|June 22, 2019
Low LDL Cholesterol by PCSK9 Variation Reduces Cardiovascular MortalityMarianne Benn, Anne Tybjærg-Hansen, Børge G Nordestgaard
Cardiovascular Research|July 30, 2023
Genetic variation in solute carrier family 5 member 2 mimicking sodium-glucose co-transporter 2-inhibition and risk of cardiovascular disease and all-cause mortality: reduced risk not explained by lower plasma glucoseLouise E Bechmann, Frida Emanuelsson, Børge G Nordestgaard, et al.
Pageof 11